DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4572-4586

  Bernier Latmani, Jeremiah ^a   Cisarovsky, Christophe ^a   Demir, Cansaran Saygili ^a   Bruand, Marine ^a   Jaquet, Muriel ^a   Davanture, Suzel ^a   Ragusa, Simone ^a   Siegert, Stefanie ^b   Dormond, Olivier ^a   Benedito, Rui ^c   Radtke, Freddy ^d   Luther, Sanjiv A ^b   Petrova, Tatiana V ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE LIGAND 4 PROTEIN; FAT; NOTCH RECEPTOR; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; DLL4 PROTEIN, MOUSE; FAT INTAKE; KDR PROTEIN, MOUSE; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT INTAKE; GENE INACTIVATION; IMMUNOCOMPETENT CELL; INTESTINE LYMPH; INTESTINE LYMPHATIC TISSUE; LIPID TRANSPORT; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGENERATIVE ABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; LYMPH VESSEL; METABOLISM; MUTANT MOUSE STRAIN; PHARMACOLOGY; PHYSIOLOGY; REGENERATION; SMALL INTESTINE;

ANIMALS; DIETARY FATS; INTESTINE, SMALL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; RECEPTORS, NOTCH; REGENERATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84948808413     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI82045     Document Type: Article

References (82)

1. Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell. 2013;154(2):274-284.
2. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity. 2011;35(1):13-22.
3. Gayer CP, Basson MD. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 2009;21(8):1237-1244.
4. Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol. 2012;5(3):232-239.
5. Kim KE, Sung HK, Koh GY. Lymphatic development in mouse small intestine. Dev Dyn. 2007;236(7):2020-2025.
6. Xu YL, et al. Neuropilin-2 mediates VEG-F-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol. 2010;188(1):115-130.
7. Tammela T, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454(7204):656-660.
8. Jang JY, et al. Conditional ablation of LYVE-1+-cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes. Blood. 2013;122(13):2151-2161.
9. Jurisic G, Sundberg JP, Detmar M. Blockade of VEGF Receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement. Inflamm Bowel Dis. 2013;19(9):1983-1989.
10. D'Alessio S, et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest. 2014;124(9):3863-3878.
11. Chen L, et al. Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. J Cell Biol. 2010;189(3):417-424.
12. Mouta-Bellum C, et al. Organ-specific lymphang-iectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85α, p55α, and p50α. Dev Dyn. 2009;238(10):2670-2679.
13. Norrmen C, et al. Liprin β1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity. Blood. 2010;115(4):906-909.
14. van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241-260.
15. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008;8(6):411-420.
16. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity. 2009;31(3):401-411.
17. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeosta-sis. Nat Rev Microbiol. 2011;9(5):356-368.
18. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol. 2008;8(6):435-446.
19. Garrett WS, Gordon JI, Glimcher LH. Homeo-stasis and inflammation in the intestine. Cell. 2010;140(6):859-870.
20. Terada N, Ohno N, Murata S, Katoh R, Stallcup W, Ohno S. Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines. Histochem Cell Biol. 2006;126(4):483-490.
21. Mifflin RC, Pinchuk IV, Saada JI, Powell DW. Intestinal myofibroblasts: targets for stem cell therapy. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G684-G696.
22. Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol. 2011;73:213-237.
23. Womack WA, Barrowman JA, Graham WH, Benoit JN, Kvietys PR, Granger DN. Quantitative assessment of villous motility. Am J Physiol. 1987;252(2 pt 1):G250-G256.
24. Madison B, Braunstein K, Kuizon E, Portman K, Qiao X, Gumucio D. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development. 2005;132(2):279-289.
25. Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol. 2014;15(12):802-812.
26. Planas-Paz L, Strilic B, Goedecke A, Breier G, Fassler R, Lammert E. Mechanoinduction of lymph vessel expansion. EMBO J. 2012;31(4):788-804.
27. Bazigou E, et al. Integrin-alpha 9 Is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17(2):175-186.
28. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200(4):488-499.
29. Malanchi I, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011481(7379):85-89.
30. Kikuchi Y, et al. Periostin is expressed in per-icryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem. 2008;56(8):753-764.
31. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464-478.
32. Schulte-Merker S, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193(4):607-618.
33. Kamba T, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006;290(2):H560-H576.
34. Yang Y, et al. Anti-VEGF-and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci USA. 2013;110(29):12018-12023.
35. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98(6):769-778.
36. Roca C, Adams RH. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 2007;21(20):2511-2524.
37. Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by Notch. Dev Cell. 2009;16(2):196-208.
38. Niessen K, et al. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood. 2011;118(7):1989-1997.
39. Fatima A, et al. Murine Notch1 is required for lymphatic vascular morphogenesis during development. Dev Dyn. 2014;243(7):957-964.
40. Zheng W, et al. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood. 2011;118(4):1154-1162.
41. Murtomaki A, et al. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium. Development. 2013;140(11):2365-2376.
42. Jakobsson L, et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol. 2010;12(10):943-953.
43. del Toro R, et al. Identification and functional analysis of endothelial tip cell-enriched genes. Blood. 2010;116(19):4025-4033.
44. Hellstrom M, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007;445(7129):776-780.
45. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature. 2007;445(7129):781-784.
46. Suchting S, et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA. 2007;104(9):3225-3230.
47. dela Paz NG, D'Amore PA. Arterial versus venous endothelial cells. Cell Tissue Res. 2009;335(1):5-16.
48. Stenzel D, et al. Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep. 2011;12(11):1135-1143.
49. Nowotschin S, Xenopoulos P, Schrode N, Had-jantonakis AK. A bright single-cell resolution live imaging reporter of Notch signaling in the mouse. BMC Dev Biol. 2013;13:15.
50. Gale NW, et al. Haploinsufficiency of Δ-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA. 2004;101(45):15949-15954.
51. Shutter JR, et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000;14(11):1313-1318.
52. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. 2002;20(1):87-90.
53. Benedito R, et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature. 2012;484(7392):110-114.
54. Benedito R, et al. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angio-genic stimuli. BMC Dev Biol. 2008;8:117.
55. Jeltsch M, Leppanen V-M, Saharinen P, Alitalo K. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol. 2013;5(9):a009183.
56. Lobov IB, et al. Δ-Like ligand 4 (DII4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA. 2007;104(9):3219-3224.
57. Prewett M, et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 1999;59(20):5209-5218.
58. Pytowski B, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst. 2005;97(1):14-21.
59. Randolph GJ, Miller NE. Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest. 2014;124(3):929-935.
60. Baluk P, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349-2362.
61. Pflicke H, Sixt M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med. 2009;206(13):2925-2935.
62. Yao LC, Baluk P, Srinivasan RS, Oliver G, McDonald DM. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am J Pathol. 2012;180(6):2561-2575.
63. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010;10(2):131-144.
64. Hallback DA, Jodal M, Mannischeff M, Lundgren O. Tissue osmolality in intestinal villi of four mammals in vivo and in vitro. Acta Physiol Scand. 1991;143(3):271-277.
65. Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15(1):19-33.
66. Izumi N, Helker C, Ehling M, Behrens A, Herzog W, Adams RH. Fbxw7 controls angiogenesis by regulating endothelial Notch activity. PLoS One. 2012;7(7):e41116.
67. Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014;507(7492):376-380.
68. Bentley K, et al. The role of differential VE-cad-herin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol. 2014;16(4):309-321.
69. Dartsch N, Hägerling R, Kiefer F, Vestweber D. Fusing VE-cadherin to α-catenin impairs fetal liver hematopoiesis and lymph but not blood vessel formation. Mol Cell Biol. 2014;34(9):1634-1648.
70. Karpanen T, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol. 2006;169(2):708-718.
71. Yao LC, et al. Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-c overexpression during a critical period. Circ Res. 2014;114(5):806-822.
72. Makinen T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7(2):199-205.
73. Previs RA, Coleman RL, Harris AL, Sood AK. Molecular pathways: translational and therapeutic implications of the notch signaling pathway in cancer. Clin Cancer Res. 2015;21(5):955-961.
74. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231-248.
75. Koch U, et al. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thy-mic T cell lineage commitment. J Exp Med. 2008;205(11):2515-2523.
76. Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M. Efficient, induc-ible Cre-recombinase activation in vascular endothelium. Genesis. 2008;46(2):74-80.
77. Srinivas S, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001;1:4.
78. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA. 2002;99(24):15451-15455.
79. Sabine A, et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control Connexin37 and Calcineurin during lymphatic-valve formation. Dev Cell. 2012;22(2):430-445.
80. Shayan R, et al. A system for quantifying the patterning of the lymphatic vasculature. Growth Factors. 2007;25(6):417-425.
81. Zudaire E, Gambardella L, Kurcz C, Vermeren S. A computational tool for quantitative analysis of vascular networks. PLoS One. 2011;6(11):e27385.
82. Pellegrinet L, et al. Dll1-and Dll4-mediated Notch signaling are required for homeosta-sis of intestinal stem cells. Gastroenterology. 2011;140(4):1230-1240.e1237.